U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06869135) titled 'Saliva and Extracellular Vesicles for Neurodegenerative Diseases' on March 05.
Brief Summary: Early diagnosis of Neurodegenerative diseases (NDDs) and accurate patient profiling are key goals needed to tailor prompt personalized therapeutic strategies that can significantly impact disease progression and patients' quality of life. The project will validate a novel, cost-effective and quick biophotonic-based method for early and differential diagnosis of NDDs (Parkinson's disease, atypical parkinsonisms, Alzheimer's disease) and for routine clinical monitoring of NDD progression (longitudinal study). Raman spectroscopy (RS) will be ...